{"id":"https://openalex.org/W17364917","doi":null,"title":"R\u00f4le des cellules tueuses naturelles dans le m\u00e9canisme d'action du rituximab : influence du polymorphisme de FCGR3A sur la r\u00e9ponse cytotoxique et \u00e9tude de la r\u00e9ponse cytokinique","display_name":"R\u00f4le des cellules tueuses naturelles dans le m\u00e9canisme d'action du rituximab : influence du polymorphisme de FCGR3A sur la r\u00e9ponse cytotoxique et \u00e9tude de la r\u00e9ponse cytokinique","alternate_titles":[],"publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W17364917","mag":"17364917"},"language":"fr","primary_location":{"id":"pmh:hdl:10068/786225","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10068/786225","pdf_url":null,"source":{"id":"https://openalex.org/S4377196900","display_name":"OpenGrey (Institut de l'Information Scientifique et Technique)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1295345811","host_organization_name":"Institut de l'Information Scientifique et Technique","host_organization_lineage":["https://openalex.org/I1295345811"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"U - Thesis"},"parent_works":[],"lineage":["https://openalex.org/W17364917"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054298177","display_name":"S\u00e9bastien Dall\u2019Ozzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S\u00e9bastien Dall\u2019Ozzo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5054298177"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9110000133514404},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9369999766349792},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.843999981880188},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cytokine-response","display_name":"cytokine response","score":0.9399999976158142},{"id":"https://openalex.org/keywords/genotyping-methods","display_name":"genotyping methods","score":0.4970000088214874},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5716965198516846},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42357444763183594},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20537230372428894}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:hdl:10068/786225","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10068/786225","pdf_url":null,"source":{"id":"https://openalex.org/S4377196900","display_name":"OpenGrey (Institut de l'Information Scientifique et Technique)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1295345811","host_organization_name":"Institut de l'Information Scientifique et Technique","host_organization_lineage":["https://openalex.org/I1295345811"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"U - Thesis"},{"id":"mag:17364917","doi":null,"is_oa":false,"landing_page_url":"https://www.theses.fr/2004TOUR4046","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1914229355","https://openalex.org/W1124826568","https://openalex.org/W4408813507","https://openalex.org/W2952618581","https://openalex.org/W2044360617","https://openalex.org/W2589949248","https://openalex.org/W2111262648","https://openalex.org/W4372352738"],"abstract_inverted_index":{"Le":[0],"rituximab":[1,100],"est":[2],"un":[3],"anticorps":[4],"monoclonal":[5],"chimerique":[6],"anti-CD20":[7],"utilise":[8],"actuellement":[9],"dans":[10,46],"le":[11,82],"traitement":[12],"des":[13,77,118,123],"lymphomes":[14],"non-hodgkiniens":[15],"folliculaire":[16],"et":[17,40,101,121],"agressif.":[18],"L'equipe":[19],"d'acceuil":[20],"EA3853":[21],"a":[22,26,63],"ete":[23],"la":[24,35,47,94,97],"premiere":[25],"montrer":[27],"l'influence":[28,89],"du":[29,31,90,128],"polymorphisme":[30,91],"gene":[32],"FCGR3A":[33,92],"sur":[34,93],"reponse":[36],"clinique":[37],"au":[38],"rituximab,":[39],"notre":[41],"travail":[42],"de":[43,49,58,69,99],"these":[44],"s'inscrit":[45],"continuite":[48],"cette":[50],"decouverte.":[51],"Nous":[52,72],"avons":[53,73,87,110],"d'abord":[54],"developpe":[55],"une":[56],"methode":[57],"genotypage":[59],"FCGR3A-158V/F":[60],"originale":[61],"adaptee":[62],"l'analyse":[64],"individuelle":[65],"ainsi":[66],"qu'a":[67],"celle":[68],"series":[70],"importantes.":[71],"ensuite":[74],"etudie":[75],"l'activation":[76],"cellules":[78,106,124],"NK":[79,125],"induite":[80],"par":[81,104],"rituximab.":[83],"En":[84],"particulier,":[85],"nous":[86,109],"montre":[88],"relation":[95],"entre":[96],"concentration":[98],"l'ADCC":[102],"exercee":[103],"les":[105,112],"NK,":[107],"puis":[108],"compare":[111],"niveaux":[113],"d'activation":[114],"requis":[115],"pour":[116],"l'induction":[117],"reponses":[119],"cytotoxique":[120],"cytokinique":[122],"apres":[126],"l'engagement":[127],"Fc\uf067RIIIa.":[129]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W17364917","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
